During the past decade, Clinica CIMCA conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 3 clinical trials were completed, i.e. on average, 17.6% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clinica CIMCA" are "Non-Small Cell Lung Cancer" (4 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Cervical Cancer" (2 trials), "Adenocarcinoma" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Clinica CIMCA" in a lesser frequency.

Most popular intervention types in "Clinica CIMCA" are "Drug" (16 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (8 trials), "Paclitaxel" (4 trials), "Alectinib" (3 trials), "Bevacizumab" (3 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinica CIMCA" are 14 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinica CIMCA". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Clinica CIMCA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinica CIMCA, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".